Orthofix International (OFIX) Tops Q3 EPS by 7c; Trims Guidance Range

Orthofix International (NASDAQ: OFIX) reported Q3 EPS of $0.13, $0.07 better than the analyst estimate of $0.06. Revenue for the quarter came in at $114 million versus the consensus estimate of $120.68 million.

GUIDANCE:

Orthofix International sees FY2022 EPS of $0.40-$0.55, versus prior guidance of $0.45-$0.55 and the consensus of $0.40. Orthofix International sees FY2022 revenue of $457-463 million, versus prior guidance of $455-465 million and the consensus of $461.5 million.

For earnings history and earnings-related data on Orthofix International (OFIX) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Pfizer reaffirms 2026 guidance after CFO transition news
• Syensqo SA (SYENS:BB) PT Raised to EUR74 at Deutsche Bank